Data from three RCTs show a level of ≥ 175 nmol/L, not ≥ 125 nmol/L, is an independent predictor of death and stroke.
Pharma leaders Novartis, Amgen, and Eli Lilly are advancing experimental drugs to lower lipoprotein(a), a genetic cholesterol-like particle linked to higher cardiovascular risk. While Novartis’ ...
NASHVILLE, Tenn.--(BUSINESS WIRE)--LP Building Solutions (LP), a leading manufacturer of high-performance building products, today announced the appointment of Executive Vice President, General ...
Please provide your email address to receive an email when new articles are posted on . Lipoprotein(a) should be measured in all people at least once. “Evaluation and management of Lp(a) is actionable ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results